The retinoblastoma tumor suppressor protein pRb is a key regulator of cell cycle progression and mediator of the DNA damage response. Lysine methylation at K810, which occurs within a critical Cdk phosphorylation motif, holds pRb in the hypophosphorylated growth-suppressing state. We show here that methyl K810 is read by the tandem tudor domain containing tumor protein p53 binding protein 1 (53BP1). Structural elucidation of 53BP1 in complex with a methylated K810 pRb peptide emphasized the role of the 53BP1 tandem tudor domain in recognition of the methylated lysine and surrounding residues. Significantly, binding of 53BP1 to methyl K810 occurs on E2 promoter binding factor target genes and allows pRb activity to be effectively integrated with the DNA damage response. Our results widen the repertoire of cellular targets for 53BP1 and suggest a previously unidentified role for 53BP1 in regulating pRb tumor suppressor activity.T he retinoblastoma tumor suppressor protein pRb is either directly mutated or functionally inactivated in the vast majority of human tumors (1). One of its principle roles in cells is to regulate transcription, and the E2 promoter binding factor (E2F) family of transcription factors represents one of its most important targets (2). E2F acts to regulate the expression of a variety of genes connected with cell cycle progression and cell fate (including apoptosis, senescence, and differentiation), and the physical interaction between pRb and E2F hinders transcriptional activation by E2F, which coincides with cell cycle arrest (2, 3).The tumor suppressor activity of pRb and its interaction with E2F is regulated by posttranslational modifications (4). For example, multiple cyclin-dependent kinase (Cdk) phosphorylation events occur within pRb, and pRb phosphorylation is temporally regulated as cells progress through the cell cycle, which disrupts the interaction between pRb and E2F. Other types of modification, such as acetylation in the C-terminal region, are also known to influence pRb activity (5).More recently, a role for lysine (K) methylation in pRb control has been described (6). Thus, residue K810 undergoes methylation mediated by SET [su(var), enhancer-of-zeste, trithorax] domain containing lysine methyltransferase 7 (Set7/9) (also known as SETD7/KMT7) (6). Monomethylation at K810 holds pRb in the hypophosphorylated growth suppressing state, which occurs at a mechanistic level by inhibiting the physical association of Cdk complexes with pRb and thereby blocks Cdk-dependent phosphorylation (6). This is because, in the unmethylated state, K810 acts as the essential basic residue in the Cdk consensus phosphorylation site S807 (namely SPLK, Fig. 1A), which is an early pRb phosphorylation event during cell cycle control (7). Significantly, methylation of K810 hinders recognition and subsequent phosphorylation of S807 by cyclin/ Cdk complexes (6).Here, we have elucidated a previously unidentified level of regulation imposed on pRb mediated by the methylation event at K810. In addition to inhi...